Ethical issues of compliance/adherence in the treatment of hypertension

Advances in Chronic Kidney Disease
Judith Bernardini

Abstract

The ethics of compliance suggests a conflict within the definition of compliance. Evidence-based medicine appears to provide clear pathways for clinical decisions, but, usually, the patient is not a part of the decision-making process. Physicians often develop a treatment plan and then attempt to make the therapy acceptable to the patient to achieve compliance. Interventions are tested to change patient behavior, but few are designed to consider the patient's point of view. Some suggest that the ideal patient is passive and obedient. However, few patients are either. The individual's perspective and goals most certainly affect adherence with a medical treatment and cannot be ignored. This article reviews the ethics of compliance/adherence issues. Future research of compliance might be improved if studies were designed to include patient preference in a partnership with physicians.

References

Mar 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M E O'Brien
Nov 1, 1988·Journal of the American Geriatrics Society·S KloezenA Steinberg
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Jan 1, 1986·American Journal of Nephrology·D L WolcottA R Nissenson
Feb 1, 1974·Social Science & Medicine·G V Stimson
Feb 1, 1968·American Journal of Public Health and the Nation's Health·M S Davis
Apr 1, 1995·Journal of the American Society of Nephrology : JASN·P L KimmelI Cruz
Sep 1, 1995·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·D J ClearyM S Joy
Aug 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P B DeOreo
Jan 15, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J Bernardini, B Piraino
Apr 29, 1998·Journal of Medical Ethics·S Smith
Jul 21, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J E LeggatF K Port
Apr 24, 1999·Journal of Advanced Nursing·H Kyngäs, T Lahdenperä
Jun 2, 2000·Seminars in Dialysis·B Piraino, J Bernardini
Jun 10, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J BernardiniB Piraino
Oct 27, 2001·Seminars in Dialysis·N G Kutner
Jan 31, 2002·The Annals of Pharmacotherapy·Rosalie P Patel, Stephanie D Taylor
May 31, 2002·EDTNA/ERCA Journal : Official Journal of the European Dialysis and Transplant Nurses Association, European Renal Care Association·M RivettiL d'Auria
Jul 26, 2002·Journal of Human Hypertension·L H Lindholm
Nov 20, 2002·Seminars in Dialysis·Dominic S C Raj
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Heather P McDonaldR Brian Haynes
Dec 19, 2002·The International Journal of Artificial Organs·E A RossL C Koo

❮ Previous
Next ❯

Citations

May 13, 2014·Revista clínica española·P ContheJ L Pinto
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Jan 13, 2017·Blood Pressure·Julian E MariampillaiPer Nortvedt
Jan 21, 2010·Cadernos de saúde pública·Maria Ines Battistella NemesCáritas Relva Basso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.